Article Details
Retrieved on: 2024-05-06 17:49:59
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Yale Cancer Center’s new cellular therapies like TIL and CAR T-cell therapies for melanoma and blood cancers, highlighting the importance of tracking data in advancing cancer treatments and patient survival outcomes.
Article found on: medicine.yale.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here